| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Galera Therapeutics, Inc. (GRTX) has 1 insider with recent SEC Form 4 filings, including 5 buys and 8 sells. GRTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 195.0K | $19.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 2, 2021 | West Linda | Director | Buy | 10,000 | $8.65 | $86,511.00 | +50.0% | |
| Jun 1, 2021 | Alleva Lawrence M | Director | Buy | 4,045 | $8.59 | $34,741.29 | New | |
| Jun 1, 2021 | West Linda | Director | Buy | 20,000 | $8.64 | $172,791.00 | +200.0% | |
| Feb 18, 2021 | Novo Holdings A/s58 | 10% Owner | Sell | 500,000 | $10.58 | $5,290,000.00 | -16.9% | |
| Nov 13, 2020 | Alleva Lawrence M | Director | Buy | 2,325 | $10.22 | $23,771.27 | +58.1% | |
| Nov 13, 2020 | Sussman Joel F. | Chief Accounting Officer | Sale+OE | 20,000 | $10.19 | $203,824.00 | -100% | |
| Oct 26, 2020 | Holmlund Jon T | Chief Medical Officer | Sale+OE | 2,244 | $15.00 | $33,660.00 | -100% | |
| Oct 15, 2020 | Novo Holdings A/s58 | 10% Owner | Sell | 450,000 | $11.00 | $4,950,000.00 | -13.2% | |
| Oct 6, 2020 | Holmlund Jon T | Chief Medical Officer | Sale+OE | 10,636 | $12.00 | $127,632.00 | -100% | |
| May 26, 2020 | Holmlund Jon T | Chief Medical Officer | Sale+OE | 692 | $12.00 | $8,304.00 | -100% |